Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5181364
Max Phase: Preclinical
Molecular Formula: C41H56N12O11S2
Molecular Weight: 957.11
Associated Items:
ID: ALA5181364
Max Phase: Preclinical
Molecular Formula: C41H56N12O11S2
Molecular Weight: 957.11
Associated Items:
Canonical SMILES: C[C@@H](O)[C@@H]1NC(=O)[C@@H](NC(=O)CN)CSCc2cccc(n2)CSC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC1=O
Standard InChI: InChI=1S/C41H56N12O11S2/c1-21(54)34-39(62)50-27(10-5-13-45-41(43)44)35(58)49-28(11-12-33(56)57)36(59)51-29(14-22-16-46-26-9-3-2-8-25(22)26)37(60)52-31(40(63)64)20-66-18-24-7-4-6-23(47-24)17-65-19-30(38(61)53-34)48-32(55)15-42/h2-4,6-9,16,21,27-31,34,46,54H,5,10-15,17-20,42H2,1H3,(H,48,55)(H,49,58)(H,50,62)(H,51,59)(H,52,60)(H,53,61)(H,56,57)(H,63,64)(H4,43,44,45)/t21-,27+,28+,29+,30+,31+,34+/m1/s1
Standard InChI Key: QNGWULRGLYHNTE-INDSUJOGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 957.11 | Molecular Weight (Monoisotopic): 956.3633 | AlogP: -2.25 | #Rotatable Bonds: 13 |
Polar Surface Area: 386.03 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 14 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.50 | CX Basic pKa: 11.49 | CX LogP: -7.75 | CX LogD: -7.86 |
Aromatic Rings: 3 | Heavy Atoms: 66 | QED Weighted: 0.05 | Np Likeness Score: 0.66 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):